Next Article in Journal
Prevalence and Classification of Scoliosis Among Female University Students in Saudi Arabia
Previous Article in Journal
Cervical Screening Systems in Eastern Europe and Central Asia: A Comparative Policy Evaluation
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Clinical Assessment of Dry Eye Disease in Patients with Keratoconus in Saudi Arabia

Department of Optometry, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia
*
Author to whom correspondence should be addressed.
Healthcare 2025, 13(22), 2890; https://doi.org/10.3390/healthcare13222890
Submission received: 26 August 2025 / Revised: 19 October 2025 / Accepted: 10 November 2025 / Published: 13 November 2025

Abstract

Purpose: The purpose of this study was to investigate dry eye disease (DED) characteristics in patients with keratoconus (KC) using non-invasive methods. Methods: A total of 34 participants were included in the study. Corneal topography was conducted for each participant utilizing Pentacam, followed by grouping according to the results obtained. The patients with Kmax > 47.2 D (KC) were considered the keratoconus group (n = 17). Healthy control participants with Kmax < 47.2 D were considered the control group (n = 17). Non-invasive tear breakup time (NITBUT), tear meniscus height (TMH), (OSDI) questionnaire, meibography, and lipid layer evaluation were assessed across the groups. Results: Dry eye assessment revealed that the mean non-invasive tear breakup time (NITBUT) was significantly shorter in the keratoconus group (9.88 ± 3.25 s) compared to the control group (18.94 ± 4.26 s, p < 0.001). Tear meniscus height was also reduced in the keratoconus group (0.185 ± 0.053 mm) versus the control group (0.358 ± 0.076 mm, p < 0.001). OSDI scores were higher in the keratoconus group (21.41 ± 5.93) compared to the control group (7.52 ± 5.05, p < 0.001), reflecting greater subjective dry eye symptoms. Meibography showed more severe Meibomian gland dropout in the keratoconus group (2.11 ± 0.60 vs. 0.70 ± 0.34, p < 0.001). Lipid layer evaluation showed no significant difference between groups (p = 0.070). Conclusions: These findings suggested a significant correlation between keratoconus and dry eye disease, with keratoconus patients showing reduced tear film stability, decreased tear volume, and increased meibomian gland dysfunction. While lipid layer changes were not significant, the results emphasized the need for comprehensive evaluation of ocular surface parameters in keratoconus management.

1. Introduction

Keratoconus (KC) is chronic, non-inflammatory corneal ectasia, which is associated with decreased visual acuity secondary to corneal steepening, irregular astigmatism, and central corneal scarring [1]. Several studies have demonstrated an increased risk of dry eye disease in patients with keratoconus. For instance, a cross-sectional study was performed in 2017–2018 to investigate the ocular surface alterations in patients with mild or severe KC and patients without KC. The research discovered that the mean scores of the Ocular Surface Disease Index (OSDI) were significantly higher and the mean values of TBUT and the Schirmer-I test were lower in patients with [2]. In another study, a pilot, experimental, prospective study conducted in 2013 compared the signs and symptoms of dry eye in KC patients versus healthy subjects. They found that KC patients suffer greater symptoms of dry eye and greater tear instability [3]. Dry eye disease (DED) is a multifactorial disease of the ocular surface characterized by a loss of homeostasis of the tear film and accompanied by ocular symptoms, in which tear film instability, hyperosmolarity, ocular surface inflammation and damage, and neurosensory abnormalities play etiological roles [4]. Another study in Saudi Arabia found that the prevalence of KC varies geographically, with a prevalence rate of 8.59% reported in Taif [5], while in this study, they found that the incidence of (KC) in Asir Province is 20 cases per 100,000 populations [6], and the prevalence of pediatric (KC) is 5.56% [7]. Additionally, a study found that overall prevalence of DED in Saudi Arabia is estimated to be 49.5% [8]. Dry eye disease in patients with KC has undergone thorough investigation in recent years. Keratography helps to accurately assess dry eye disease (DED). Studies have focused on assessing the correlation between dry eye disease (DED) in patients with KC using invasive methods such as the Schirmer test and vital dye assessments to investigate the relationship between DED and KC [2,3]. Given the lack of regional data using non-invasive techniques, this study aims to evaluate DED in KC patients in Saudi Arabia through non-invasive diagnostic methods and we expect to provide valuable insights into the relationship between KC and DED in the Saudi population.

2. Methodology

This cross-sectional observational study was designed to investigate and compare the prevalence and severity of DED in Saudi residents with and without KC. A representative sample of Saudi residents aged 18 to 35 years was selected, comprising 34 participants divided into two equal groups. The KC group included 17 participants diagnosed with the condition, while the control group consisted of 17 participants without KC. Participants were matched by sex and age to reduce confounding effects. Grouping of participants was based on Kmax values obtained from Pentacam measurements for the eye with the higher Kmax [9]. Individuals with Kmax greater than 47.2 D were classified as the KC group, while those with Kmax less than 47.2 D were included in the control group [10].
Participants in the KC group were recruited from Qassim University (QU) Hospital, where their diagnosis was confirmed by corneal topography. In contrast, the control group was recruited through random sampling of individuals at (QU).
The inclusion criteria for this study required participants to be 18 years or older, with a confirmed diagnosis of KC (for the KC group) and the ability to provide informed consent. Participants were excluded if they had a history of ocular surgery (except corneal cross-linking performed within the past year period), corneal infections, systemic diseases that could affect the eyes, systemic autoimmune diseases (e.g., Sjögren’s syndrome), pre-existing or ongoing treatment for DED, or if they were using topical ocular anti-inflammatory medications.
Data collection used standardized methods and tools to ensure accurate and reliable findings. Participants were first asked to complete the Ocular Surface Disease Index (OSDI) questionnaire to evaluate DED symptoms and their impact on daily activities; the validated Arabic version of the Ocular Surface Disease Index (OSDI) questionnaire was used in this study [11]. Advanced diagnostic tools were employed to obtain objective measurements. The Pentacam device (Oculus; Optikgeräte GmbH, Wetzlar, Germany) was used to assess key corneal parameters, including Kmax readings and the thinnest corneal area, while the Keratograph 5M (Oculus Optikgeräte GmbH, Wetzlar, Germany) provided detailed information on non-invasive tear breakup time, tear meniscus height, Meibomian gland morphology, and lipid layer integrity, as shown in Figure 1. Both devices were calibrated daily according to manufacturer instructions. All patient assessments were conducted between 12:00 PM and 2:00 PM to maintain consistency in the measurement conditions.
Additional clinical data, including participants’ age, gender, and ocular health history, were collected through structured interviews and a review of medical records to control for potential confounding factors. Ethical considerations were central to the study design. All participants provided informed consent before their involvement, and their confidentiality and privacy were strictly maintained throughout the research process. Participants retained the right to withdraw from the study or request the deletion of their data at any time without providing a reason.
The collected data were statistically analyzed using the Shapiro–Wilk test to assess data normality, and all the datasets failed the normality test according to the Shapiro–Wilk assessment; therefore, non-parametric tests (Wilcoxon rank-sum) were used for group comparisons. A p-value of less than 0.05 was considered statistically significant. By improving our understanding of the epidemiology of DED and its association with KC, with our findings, we aim to advance KC research and contribute to alleviating the discomfort experienced by affected patients.

3. Results

The participants’ ages ranged from 18 to 35 years, with a mean age of 23.8 ± 9.5 years. The key corneal topography parameters and dry eye test results are summarized in Table 1.
Dry eye assessment showed that the mean non-invasive tear breakup time (NITBUT) was significantly shorter in the KC group (9.88 ± 3.25 s) compared to the control group (18.94 ± 4.26 s, p < 0.001; 95% CI: 6.7–11.3). Tear meniscus height was also significantly reduced in the KC group (0.185 ± 0.053 mm) versus the control group (0.358 ± 0.076 mm, p < 0.001; 95% CI: 0.13–0.23). The OSDI questionnaire scores were notably higher in the KC group (21.41 ± 5.93) than in the control group (7.52 ± 5.05, p < 0.001; 95% CI: 10.1–17.7) as shown in Figure 2.
Meibography findings revealed a higher grade of Meibomian gland dropout in the KC group (2.11 ± 0.60) compared to the control group (0.70 ± 0.34, p < 0.001) as shown in Table 2. However, no statistically significant difference was observed between the two groups in lipid layer evaluation, with the mean lipid layer grade being 1.65 ± 0.93 in the KC group and 1.12 ± 0.60 in the control group (p = 0.070).

Relationship Between Parameters

Correlation analyses were conducted only for the parameters that showed statistically significant differences between the groups. Spearman’s rho test revealed significant correlations between clinical parameters. Kmax showed a significant negative correlation with NITBUT and TMH (p < 0.001), and a significant positive correlation with OSDI and Meibomian gland drop-out (p < 0.001), as shown in Figure 3.

4. Discussion

KC has traditionally been regarded as a non-inflammatory ectatic corneal disorder due to the absence of classical signs of inflammation. However, recent evidence has challenged this assumption. Elevated levels of inflammatory mediators—including interleukins, cytokines, and proteolytic enzymes—have been identified in the tears and on the ocular surface of patients with KC [12,13,14,15,16,17,18], suggesting that subclinical inflammation plays a role in the disease’s pathophysiology. Elevated tear levels of IL-6 and MMP-9 have been reported in both KC and dry eye, suggesting shared inflammatory pathways influencing corneal remodeling and tear instability [19,20,21]. Similarly, DED is now recognized as a multifactorial condition in which inflammation plays a central role [15,16]. Given the overlap in inflammatory mechanisms, the potential association between KC and DED has attracted growing interest. In the present investigation, the presence of tear film instability and ocular surface disruption in individuals with KC was examined in comparison to healthy controls.
Significant alterations were identified in several dry eye parameters among KC patients. Non-invasive tear breakup time (NITBUT) and tear meniscus height values were notably reduced, while Ocular Surface Disease Index (OSDI) scores and Meibomian gland dropout grades were elevated relative to control subjects. These findings point to a greater prevalence of dry eye-related signs and symptoms in the KC population. In contrast, no significant differences were observed in lipid layer thickness, suggesting that evaporative dry eye mechanisms may be less prominent or variable across individuals with KC. The relationship between KC and DED remains incompletely understood, with previous studies reporting inconsistent results. Some investigations have documented reduced TBUT and Schirmer-I values among KC patients, with varying levels of statistical significance [2,3,13,22]. Differences in sample size, disease severity, and diagnostic methodology may contribute to this variability. While certain studies reported insignificant changes in TBUT, others have demonstrated reduced tear production and corneal sensitivity, particularly in more advanced stages of the disease [2,3,22]. The implications of each key parameter (e.g., tear film stability, ocular surface staining, and symptom severity) have been discussed in relation to patient management and disease understanding. Conventional tests like fluorescein tear breakup time and the Schirmer test can disturb natural tear flow and affect accuracy [23,24]. In contrast, our results show that keratography provides a reliable, contact-free, and objective way to assess tear stability, production, and meibomian gland function [25,26]. Growing evidence supports the use of non-invasive imaging tools to improve both patient comfort and the consistency of clinical assessments [27,28,29].
In the current findings, corneal steepening (Kmax) showed significant correlations with key ocular surface parameters. Increased Kmax values were associated with reduced tear film stability (as indicated by lower NITBUT and tear meniscus height), higher symptom burden (reflected in elevated OSDI scores), and greater Meibomian gland dropout. These correlations support the hypothesis that greater disease severity in KC may be linked to more pronounced ocular surface dysfunction. Overall, these observations contribute to a growing body of literature suggesting that inflammatory activity and tear film instability may play a more prominent role in KC than previously assumed. Addressing dry eye symptoms in KC not only enhances visual comfort but may also improve patients’ daily functioning and overall quality of life. Comprehensive assessment of the ocular surface, including dry eye evaluation, appears warranted in the clinical management of KC.

5. Conclusions

In conclusion, the findings indicate an association between KC and ocular surface changes consistent with features of dry eye disease. Evidence of tear film instability, ocular surface symptoms, and Meibomian gland dysfunction in KC patients underscores the relevance of dry eye evaluation in this population. Keratoconus and dry eye disease frequently occur together, yet non-invasive diagnostic techniques are still not widely used in clinical practice. The present study demonstrates that keratography provides an effective, tear-preserving approach to assessing ocular surface health in these patients. These insights suggest that addressing ocular surface health may play a role in the broader clinical management of KC and highlight the importance of further research into the underlying mechanisms linking these conditions.

Author Contributions

S.A. conceived and designed the study, collected and analyzed the data, and drafted the manuscript. A.A. contributed to methodology, data interpretation, and manuscript review. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by Qassim University, represented by the Deanship of Graduate Studies and Scientific Research, for the financial support for this research under the number (QU-J-UG-2-2025-53612) during the academic year 1446 AH/2024 AD.

Institutional Review Board Statement

This study was approved by the Institutional Review Board/Ethical Review Board at Qassim University 21-21-10 (3 April 2024).

Informed Consent Statement

Informed consent was obtained from all subjects.

Data Availability Statement

Data are available on request from the corresponding author. The data are not publicly available due to privacy and ethical restrictions.

Acknowledgments

The authors gratefully acknowledge Qassim University, represented by the Deanship of Graduate Studies and Scientific Research, for the financial support for this research under the number (QU-J-UG-2-2025-53612) during the academic year 1446 AH/2024 AD.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Krachmer, J.H.; Feder, R.S.; Belin, M.W. Keratoconus and related noninflammatory corneal thinning disorders. Surv. Ophthalmol. 1984, 28, 293–322. [Google Scholar] [CrossRef] [PubMed]
  2. Mirza, E.; Oltulu, R.; Oltulu, P.; Mirza, G.D.; Okka, M. Dry eye disease and ocular surface characteristics in patients with keratoconus. Saudi J. Ophthalmol. 2022, 36, 117–121. [Google Scholar] [CrossRef] [PubMed]
  3. Carracedo, G.; Recchioni, A.; Alejandre-Alba, N.; Martin-Gil, A.; Crooke, A.; Morote, I.J.; Pintor, J. Signs and symptoms of dry eye in keratoconus patients: A pilot study. Curr. Eye Res. 2015, 40, 1088–1094. [Google Scholar] [CrossRef]
  4. Wolffsohn, J.S.; Benítez-Del-Castillo, J.; Loya-Garcia, D.; Inomata, T.; Iyar, G.; Liang, L.; Pult, H.; Sabater, A.L.; Starr, C.E.; Vehof, J.; et al. TFOS DEWS III Diagnostic Methodology. Am. J. Ophthalmol. 2025, 279, 387–450. [Google Scholar] [CrossRef]
  5. Althomali, T.A.; Al-Qurashi, I.M.; Al-Thagafi, S.M.; Mohammed, A.; Almalki, M. Prevalence of keratoconus among patients seeking laser vision correction in Taif area of Saudi Arabia. Saudi J. Ophthalmol. 2018, 32, 114–118. [Google Scholar] [CrossRef]
  6. Assiri, A.A.; Yousuf, B.I.; Quantock, A.J.; Murphy, P.J. Incidence and severity of keratoconus in Asir province, Saudi Arabia. Br. J. Ophthalmol. 2005, 89, 1403–1406. [Google Scholar] [CrossRef]
  7. Netto, E.A.; Al-Otaibi, W.M.; Hafezi, N.L.; Kling, S.; Al-Farhan, H.M.; Randleman, J.B.; Hafezi, F. Prevalence of keratoconus in paediatric patients in Riyadh, Saudi Arabia. Br. J. Ophthalmol. 2018, 102, 1436–1441. [Google Scholar] [CrossRef]
  8. Alkhaldi, S.A.; Allam, K.H.; Radwan, M.A.; Sweeney, L.E.; Alshammeri, S. Estimates of dry eye disease in Saudi Arabia based on a short questionnaire of prevalence, symptoms, and risk factors: The Twaiq Mountain Eye Study I. Contact Lens Anterior Eye 2023, 46, 101770. [Google Scholar] [CrossRef]
  9. Shetty, R.; Sharma, A.; Pahuja, N.; Chevour, P.; Padmajan, N.; Dhamodaran, K.; Jayadev, C.; Nuijts, R.M.M.A.; Ghosh, A.; Nallathambi, J. Oxidative stress induces dysregulated autophagy in corneal epithelium of keratoconus patients. PLoS ONE 2017, 12, e0184628. [Google Scholar] [CrossRef]
  10. Rabinowitz, Y.S. Keratoconus. Surv. Ophthalmol. 1998, 42, 297–319. [Google Scholar] [CrossRef] [PubMed]
  11. Bakkar, M.M.; El-Sharif, A.K.; Al Qadire, M. Validation of the Arabic version of the ocular surface disease index questionnaire. Int. J. Ophthalmol. 2021, 14, 1595. [Google Scholar] [CrossRef] [PubMed]
  12. Lema, I.; Durán, J.A. Inflammatory molecules in the tears of patients with keratoconus. Ophthalmology 2005, 112, 654–659. [Google Scholar] [CrossRef] [PubMed]
  13. West-Mays, J.A.; Sadow, P.M.; Tobin, T.W.; Strissel, K.J.; Cintron, C.; Fini, M.E. Repair phenotype in corneal fibroblasts is controlled by an interleukin-1 alpha autocrine feedback loop. Investig. Ophthalmol. Vis. Sci. 1997, 38, 1367–1379. [Google Scholar]
  14. Wilson, S.E.; He, Y.G.; Weng, J.; Li, Q.; McDowall, A.W.; Vital, M.; Chwang, E.L. Epithelial injury induces keratocyte apoptosis: Hypothesized role for the interleukin-1 system in the modulation of corneal tissue organization and wound healing. Exp. Eye Res. 1996, 62, 325–338. [Google Scholar] [CrossRef]
  15. Becker, J.; Salla, S.; Dohmen, U.; Redbrake, C.; Reim, M. Explorative study of interleukin levels in the human cornea. Graefe’s Arch. Clin. Exp. Ophthalmol. 1995, 233, 766–771. [Google Scholar] [CrossRef]
  16. Bosnar, D.; Dekaris, I.; Gabrić, N.; Markotić, A.; Lazić, R.; Špoljarić, N. Influence of interleukin-1α and tumor necrosis factor-α production on corneal graft survival. Croat. Med. J. 2006, 47, 59–66. [Google Scholar]
  17. Maertzdorf, J.; Osterhaus, A.D.; Verjans, G.M. IL-17 expression in human herpetic stromal keratitis: Modulatory effects on chemokine production by corneal fibroblasts. J. Immunol. 2002, 169, 5897–5903. [Google Scholar] [CrossRef]
  18. Balasubramanian, S.A.; Pye, D.C.; Willcox, M.D. Levels of lactoferrin, secretory IgA and serum albumin in the tear film of people with keratoconus. Exp. Eye Res. 2012, 96, 132–137. [Google Scholar] [CrossRef]
  19. Santos, A.; José Filho, A.P.; Cenedeze, M.A.; Hiyane, M.I.; Amano, M.T.; Cruz, M.C.; Hirai, F.E.; Camara, N.O.; de Sousa, L.B.; de Oliveira, L.A. Increased inflammatory mediators in the ocular surface tissue in keratoconus. Mol. Vis. 2024, 30, 279. [Google Scholar]
  20. Stern, M.E.; Pflugfelder, S.C. Inflammation in dry eye. Ocul. Surf. 2004, 2, 124–130. [Google Scholar] [CrossRef]
  21. Nichani, P.A.; Solomon, B.; Trinh, T.; Mimouni, M.; Rootman, D.; Singal, N.; Chan, C.C. Investigating the role of inflammation in keratoconus: A retrospective analysis of 551 eyes. Eur. J. Ophthalmol. 2023, 33, 35–43. [Google Scholar] [CrossRef] [PubMed]
  22. Dogru, M.; Karakaya, H.; Özçetin, H.; Ertürk, H.; Yücel, A.; Özmen, A.; Baykara, M.; Tsubota, K. Tear function and ocular surface changes in keratoconus. Ophthalmology 2003, 110, 1110–1118. [Google Scholar] [CrossRef] [PubMed]
  23. Wolffsohn, J.S.; Arita, R.; Chalmers, R.; Djalilian, A.; Dogru, M.; Dumbleton, K.; Gupta, P.K.; Karpecki, P.; Lazreg, S.; Pult, H.; et al. TFOS DEWS II diagnostic methodology report. Ocul. Surf. 2017, 15, 539–574. [Google Scholar] [CrossRef] [PubMed]
  24. Bron, A.J.; de Paiva, C.S.; Chauhan, S.K.; Bonini, S.; Gabison, E.E.; Jain, S.; Knop, E.; Markoulli, M.; Ogawa, Y.; Perez, V.; et al. Tfos dews ii pathophysiology report. Ocul. Surf. 2017, 15, 438–510. [Google Scholar] [CrossRef]
  25. Hong, J.; Sun, X.; Wei, A.; Cui, X.; Li, Y.; Qian, T.; Wang, W.; Xu, J. Assessment of tear film stability in dry eye with a newly developed keratograph. Cornea 2013, 32, 716–721. [Google Scholar] [CrossRef]
  26. Mostafa, E.M.; Abdellah, M.M.; Elhawary, A.M.; Mounir, A. Research Article Noncontact Meibography in Patients with Keratoconus. J. Ophthalmol. 2019, 2019, 2965872. [Google Scholar]
  27. Craig, J.P.; Nichols, K.K.; Akpek, E.K.; Caffery, B.; Dua, H.S.; Joo, C.K.; Liu, Z.; Nelson, J.D.; Nichols, J.J.; Tsubota, K.; et al. TFOS DEWS II definition and classification report. Ocul. Surf. 2017, 15, 276–283. [Google Scholar] [CrossRef]
  28. Willcox, M.D.; Argüeso, P.; Georgiev, G.A.; Holopainen, J.M.; Laurie, G.W.; Millar, T.J.; Papas, E.B.; Roll, J.P.; Schmidt, T.A.; Stahl, U.; et al. TFOS DEWS II tear film report. Ocul. Surf. 2017, 15, 366–403. [Google Scholar] [CrossRef]
  29. Shorter, E.; Harthan, J.; Nau, A.; Fogt, J.; Cao, D.; Schornack, M.; Nau, C. Dry eye symptoms in individuals with keratoconus wearing contact lenses. Eye Contact Lens 2021, 47, 515–519. [Google Scholar] [CrossRef]
Figure 1. Photograph from a keratography device used to evaluate the tear film.
Figure 1. Photograph from a keratography device used to evaluate the tear film.
Healthcare 13 02890 g001
Figure 2. Graph 1 shows the comparison of keratoconus and control groups for NITBUT, Graph 2 for tear meniscus height (TMH), and Graph 3 for OSDI score.
Figure 2. Graph 1 shows the comparison of keratoconus and control groups for NITBUT, Graph 2 for tear meniscus height (TMH), and Graph 3 for OSDI score.
Healthcare 13 02890 g002
Figure 3. Graph 4 shows the correlations between Kmax and non-invasive tear breakup time (NITBUT) (p = −0.632). Graph 5 shows the correlation between Kmax and tear meniscus height (TMH) (p = −0.758). Graph 6 shows the correlation between Kmax and OSDI score (p = 0.794). Graph 7 shows the correlation between Kmax and meibomian gland drop-out grade (p = 0.582).
Figure 3. Graph 4 shows the correlations between Kmax and non-invasive tear breakup time (NITBUT) (p = −0.632). Graph 5 shows the correlation between Kmax and tear meniscus height (TMH) (p = −0.758). Graph 6 shows the correlation between Kmax and OSDI score (p = 0.794). Graph 7 shows the correlation between Kmax and meibomian gland drop-out grade (p = 0.582).
Healthcare 13 02890 g003
Table 1. Clinical characteristics of the groups.
Table 1. Clinical characteristics of the groups.
Mean ± SDp
Keratoconus GroupControl Group
Age (years)25.9 ± 6.822.6 ± 8.40.890
Kmax (dioptry)56.85 ± 8.41 D43.59 ± 1.81 D<0.0001
Thinnest Corneal thickness (µm)419.52 ± 58.61 µm535.47 ± 38.34 µm<0.0001
NITBUT (s)9.88 ± 3.25 s18.94 ± 4.26 s<0.0001
TMH (mm)0.185 ± 0.053 mm0.358 ± 0.076 mm<0.0001
OSDI score21.41 ± 5.937.52 ± 5.05<0.0001
Table 2. Meibomian gland drop-out grades of the groups.
Table 2. Meibomian gland drop-out grades of the groups.
Mean ± SDp
Keratoconus GroupControl Groupp
Grade 0 (n)08<0.001
Grade 1 (n)26<0.001
Grade 2 (n)113<0.001
Grade 3 (n)40<0.001
Meibomian glands were scored using the following grades: Grade 0: No loss of meibomian glands. Grade 1: Area loss was less than one-third of the total meibomian gland area. Grade 2: Area loss was between one-third and two-thirds. Grade 3: Area loss was more than two-thirds.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Alshammeri, S.; Alharbi, A. Clinical Assessment of Dry Eye Disease in Patients with Keratoconus in Saudi Arabia. Healthcare 2025, 13, 2890. https://doi.org/10.3390/healthcare13222890

AMA Style

Alshammeri S, Alharbi A. Clinical Assessment of Dry Eye Disease in Patients with Keratoconus in Saudi Arabia. Healthcare. 2025; 13(22):2890. https://doi.org/10.3390/healthcare13222890

Chicago/Turabian Style

Alshammeri, Saleh, and Azzam Alharbi. 2025. "Clinical Assessment of Dry Eye Disease in Patients with Keratoconus in Saudi Arabia" Healthcare 13, no. 22: 2890. https://doi.org/10.3390/healthcare13222890

APA Style

Alshammeri, S., & Alharbi, A. (2025). Clinical Assessment of Dry Eye Disease in Patients with Keratoconus in Saudi Arabia. Healthcare, 13(22), 2890. https://doi.org/10.3390/healthcare13222890

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop